phone icon Int'l : +1-503-894-6022
Allied Market Research
0
Shopping Cart is Empty..
$ 0

PTCA Balloon Catheters Market Expected to Reach $1,431 Million by 2023

report_img

quote There has been an increased use of drug-eluting balloons in the past few years. The use of drug-eluting balloons has resulted in the reduction in the use of vessel implants (such as stents), which may cause vessel fracture. In addition, drug-eluting balloons are safe and they provide the highest rate of restoration of normal blood flow when compared to other balloon catheters.‐ She further added that ‐reclassification of some of the PTCA catheters by FDA would propel the growth of market as these catheters would come under class II and would not require premarket approval for sale.quote


Pallavi Jaiswal, Senior Analyst, Healthcare Research at AMR



Need More Information?

Talk to Rahul Thakur

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

call   Toll Free : +1-800-792-5285

call   UK : + 44-845-528-1300

call   Hong Kong : + 852-301-84916

call   India (Pune) : +91 20 66346060

call   Fax : +1⟨855⟩550-5975

mail  help@alliedmarketresearch.com

 

According to a new report published by Allied Market Research, titled, PTCA Balloon Catheters Market: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global PTCA balloon catheters market was valued at $1,064 million in 2016, and is expected to reach $1,431 million by 2023, growing at a CAGR of 4.3% from 2017 to 2023.

Access Full Summary at: https://www.alliedmarketresearch.com/percutaneous-transluminal-coronary-angioplasty-PTCA-balloon-catheters-market

Percutaneous transluminal coronary angioplasty (PTCA) is a minimally-invasive procedure used to open blocked or narrowed coronary arteries. PTCA balloons are inflated inside a blocked coronary artery to open up the blockage and allow smooth blood flow. The use of PTCA balloon catheters is on a continuous rise, as it ensures sufficient plaque removal, and optimum patient comfort through a minimally invasive procedure.

Increase in aging population and changes in lifestyle of people, technological advancements, changes in FDA policy, and rise in prevalence of cardiovascular disorders are expected to drive the market growth. However, availability of alternative therapies, and complications associated with PTCA balloon catheters restrain this growth. The upsurge in demand for minimally invasive surgeries, rise in disposable incomes, and growth prospects in emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for market growth during the forecast period.

The normal balloon catheter segment is expected to maintain its dominant position during the analysis period, owing to reduced complications associated with them when compared to other product types. The drug eluting balloon catheter segment is expected to grow at a rapid CAGR of 4.7% throughout the forecast period.

There has been an increased use of drug-eluting balloons in the past few years. The use of drug-eluting balloons has resulted in the reduction in the use of vessel implants (such as stents), which may cause vessel fracture. In addition, drug-eluting balloons are safe and they provide the highest rate of restoration of normal blood flow when compared to other balloon catheters.

Key Findings of the PTCA Balloon Catheters Market:

  • Polyolefin copolymer (POC) accounted for more than half of the materials segment in 2016
  • The RX balloon catheter segment accounted for more than four-fifths of the global market in 2016
  • Drug eluting balloon catheter is expected to grow at the highest CAGR of 4.7% from 2017 to 2023
  • The semi-compliant segment accounted for four-fifths of the global market in 2016
  • Asia-Pacific is expected to grow at the highest CAGR of 5.7%, from 2017 to 2023

North America accounted for more than two-fifths of the global market in 2016, and is expected to remain dominant throughout the forecast period. This is attributed to the increase in incidence of cardiovascular diseases; growth in geriatric population; and changing lifestyle of people that leads to cardiac abnormalities. In addition, high adoption rate of technologically advanced devices and presence of highly sophisticated healthcare infrastructure are expected to present new growth opportunities to the players in this market.

The major companies profiled in the report include The list of key players profiled in this report include Abbott Laboratories, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc., Medtronic plc, MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION.


First time buyer?   Click here..                                         
To get this report  
 
 

Why Allied Market Research?

 

Inflallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to eliminate redundant information to provide valued information and save time of the reader

 

Further Readings

rep-img

Aug 2017

Oilseeds Market

Read More >
rep-img

Aug 2017

IoT in Manufacturing Market

Read More >
rep-img

Aug 2017

Asia-Pacific Medical Carts Market

Read More >
rep-img

Aug 2017

Color Cosmetics Market

Read More >
 

Get fresh content delivered weekly

Get insights on topics that matter to your business. Stay updated on the areas that interest you.